News

From IRB Barcelona

 

From our Lab

  • October 5, 2016

    A Cancer Genome Interpreter to identify driver and actionable alterations in tumors

    The use of genomic information is becoming a key piece of the oncology toolkit to make informed decisions aimed to improve the management of the disease and increase the cost-effectiveness of available therapies.

  • April 14, 2016

    Our paper demonstrating that proteins bound to DNA impair Nucleotide Excision Repair published in Nature

    I am very happy to announce that our manuscript describing the increased mutation rate in Transcription Factor Binding Sites (TFBS) in melanomas and lung tumors has been published in today's issue of Nature. In the manuscript we demonstrate that this accumulation is due to the impairment of Nucleotide Excision Repair (NER) activity by proteins bound to DNA.

  • February 4, 2016

    ERC-consolidator granted to our lab to find noncoding cancer drivers

    We are happy to announce that our lab has been awarded an European Research Council Consolidator Grant. ERC-consolidator grants are designed “To fund top researchers of any nationality and age, [...]

  • March 17, 2015

    New IntOGen web to explore driver genes across cancer types

    Coinciding with the publication of our latest paper, on Monday (9 March 2015) (See blog post) we have crafted a new IntOGen interface which presents the results of the [...]

  • March 9, 2015

    In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals novel targeting opportunities

    We are pleased to announce the publication of our paper in Cancer Cell describing the landscape of anti-cancer targeted therapeutic opportunities across a cohort of patients of twenty [...]

  • December 19, 2014

    How to generate mutation distribution and frequency plots?

    Let’s plot some mutations! Easy, right? For our next iteration of the IntOGen database, we wanted to add figures that represent the mutation distribution across the protein sequence. [...]

  • August 26, 2014

    OncodriveROLE predicts activating and loss of function cancer driver genes

    We are pleased to announce that the Oncodrive methods family has a new member: OncodriveROLE, an approach to classify cancer drivers into loss of function and activating roles. [...]

  • August 7, 2014

    Molecular subtypes of human cancer

    Cancers are typically classified depending on their tissue of origin. However, novel large-scale genomic studies are providing more detailed molecular characterizations of tumors, and thus bring about the [...]

  • July 16, 2014

    How to identify oncogenic driver mutations: a review of bioinformatics approaches

    Recently, at least three articles have reviewed the ensemble of bioinformatics tools developed in the past few years to understand the alterations that plague the genome and transcriptome [...]

  • July 14, 2014

    Mutual exclusion statistics and data events in Gitools

    We’re pleased to announce another incremental release of Gitools, version 2.2. Amongst the many improvements (listed at the bottom of this post) we’d like to highlight the effort [...]